Alternative Halogenated Flame Retardants versus PBDEs in the Global Marine Environment – Occurrence, Distribution and Long-Range Atmospheric Transport toward the Polar Regions

Halogenated flame retardants (HFRs) have been applied since the 1960s in various industrial and consumer products to protect humans as well as private and public possessions. In the past decade polybrominated diphenyl ethers (PBDEs), formerly the major applied HFRs were widely restricted and adopted as Persistent Organic Pollutants (POPs) in the Stockholm Convention due to their adverse effects on humans and the environment as well as their ubiquitous occurrence in the global environment. Besides PBDEs, various alternative HFRs have been applied for decades as well, or were recently developed to replace PBDEs. However, their potential adverse properties, environmental distribution and fate are largely unknown. Therefore, this thesis addresses the global occurrence, distribution and transport of alternative HFRs versus PBDEs in the marine atmosphere and seawater toward the Polar Regions in order to examine their longrange atmospheric transport (LRAT) potential. This thesis presents the first data on alternative HFRs in the atmosphere of the marine environment and the Polar Regions. Alternative brominated flame retardants (BFRs), Dechlorane compounds and PBDEs were investigated in high-volume air and seawater samples taken along several sampling transects in the Atlantic Ocean, Pacific Ocean and Indian Ocean toward the Polar Regions of the Arctic and Antarctic. In addition, three sampling cruises were conducted in the German Bight, North Sea. Several alternative HFRs were detected in the global marine atmosphere and seawater with hexabromobenzene (HBB), pentabromotoluene (PBT), pentabromobenzene (PBBz), 2,3- dibromopropyl-2,4,6-tribromophenyl ether (DPTE) and Dechlorane Plus (DP) being the predominant compounds which were observed in concentrations similar or even higher than PBDEs. Total atmospheric concentrations ranged from <1 pg m-3 over the open oceans up to 42 pg m-3 over the East Indian Archipelago. Seawater concentrations ranged from <1 pg L-1 in open ocean seawater up to 21 pg L-1 in coastal regions, while estuarine concentrations reached up to 6800 pg L-1. Overall, the comparison revealed that alternative HFRs dominate versus PBDEs in air and seawater, both in coastal regions as well as the Polar Regions, showing a shift from PBDEs toward alternative HFR in the marine atmosphere and seawater. The distribution in the global atmosphere was strongly influenced by the proximity to potential source regions and the pathway of the sampled air masses. Highest concentrations were observed in continentally influenced air masses, while low background concentrations occurred during sampling of oceanic remote air masses. In general, Western Europe, East and Southeast Asia but also Africa were identified as source regions for the marine environment, especially for alternative HFRs as well as BDE-209. In contrast, relatively low peak concentrations of the PBDE congeners of the Penta- and OctaBDE mixtures under continental influence were observed, indicating limited emissions of legacy PBDEs. The dry air-seawater gas exchange estimation showed that the atmosphere is a source for seawater resulting in net deposition into the global oceans after atmospheric emissions and transport, both in coastal regions as well as in the open oceans. Besides atmospheric depositions, riverine discharge was shown to act as source for coastal environments. The investigation of sampling transects toward the Polar Regions revealed that several alternative HFRs – in particular HBB, PBT, DPTE, PBBz and DP – undergo LRAT toward the Polar Regions in an extent similar to PBDEs and, therefore, meet the LRAT criterion of POPs under the Stockholm Convention. DP was found to undergo LRAT attached to airborne particles whereby stereoselective LRAT differences were shown for the two DP stereoisomers. With respect to LRAT, the results of this thesis therefore imply that alternative HFRs – in particular HBB, PBT, DPTE and DP – aren’t suitable replacements for PBDEs, but chemicals of emerging global environmental concern and possible future POPs

Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins

Background: Capillary zone electrophoresis (CZE) is a well-accepted automated method used to separate serum proteins and detect monoclonal components. CZE uses ultraviolet detection at 214nm to directly quantify proteins via peptide bonds. Any substance that absorbs at 214nm and is present in serum can potentially interfere with CZE analysis. This has been reported for radio-contrast media and antibiotics. Methods: Here we describe a peak on the anode side of the α2-globulin fraction caused by the antibiotic ampicillin-sulbactam (Unacid®). Results and conclusions: Extra peaks that can be misinterpreted as monoclonal components can be present in almost all electrophoretic fractions of CZE. Immunosubtraction or immunofixation is always required to rule out these conditions. Clin Chem Lab Med 2008;46:1468-

The ribosome receptors Mrx15 and Mba1 jointly organize cotranslational insertion and protein biogenesis in mitochondria

Mitochondrial gene expression in Saccharomyces cerevisiae is responsible for the production of highly hydrophobic subunits of the oxidative phosphorylation system. Membrane insertion occurs cotranslationally on membrane-bound mitochondrial ribosomes. Here, by employing a systematic mass spectrometry-based approach, we discovered the previously uncharacterized membrane protein Mrx15 that interacts via a soluble C-terminal domain with the large ribosomal subunit. Mrx15 contacts mitochondrial translation products during their synthesis and plays, together with the ribosome receptor Mba1, an overlapping role in cotranslational protein insertion. Taken together, our data reveal how these ribosome receptors organize membrane protein biogenesis in mitochondria

Application of a Synthetic Turbulence Generator in Aircraft and Turbomachinery Aerodynamics

Methods for generating synthetic turbulent fluctuations in numerical flow simulations have gained increasing attention over the past years. Applications of synthetic turbulence generators (STG) range from initializing whole turbulent flow fields to posing turbulent boundary conditions in LES simulations to generating acoustic sources for the computation of sound propagation. In the DLR project ADaMant one specific method, the NTS-STG, has been applied in two rather different fields with different underlying mechanisms in mind: on the one hand, in order to allow for local wall-modelled LES (WM-LES) on the surface of e.g. an aircraft wing or engine nacelle, the STG is applied inside the fully turbulent boundary layer to ensure quick transition from RANS to WMLES. On the other hand, the STG is used to provide realistic ambient turbulence levels in the freestream of turbomachine components, in order to simulate transitional (laminar/turbulent) flow. Both types of applications of the NTS-STG are put in a common context, highlighting their specific requirements on the STG as well as current deficiencies and potential improvements

Translational potential of metabolomics on animal models of inflammatory bowel disease:a systematic critical review

In the development of inflammatory bowel disease (IBD), the gut microbiota has been established as a key factor. Recently, metabolomics has become important for understanding the functional relevance of gut microbial changes in disease. Animal models for IBD enable the study of factors involved in disease development. However, results from animal studies may not represent the human situation. The aim of this study was to investigate whether results from metabolomics studies on animal models for IBD were similar to those from studies on IBD patients. Medline and Embase were searched for relevant studies up to May 2017. The Covidence systematic review software was used for study screening, and quality assessment was conducted for all included studies. Data showed a convergence of ~17% for metabolites differentiated between IBD and controls in human and animal studies with amino acids being the most differentiated metabolite subclass. The acute dextran sodium sulfate model appeared as a good model for analysis of systemic metabolites in IBD, but analytical platform, age, and biological sample type did not show clear correlations with any significant metabolites. In conclusion, this systematic review highlights the variation in metabolomics results, and emphasizes the importance of expanding the applied detection methods to ensure greater coverage and convergence between the various different patient phenotypes and animal models of inflammatory bowel disease

Decentralized Documentation of Maritime Traffic Incidents to Support Conflict Resolution

For the investigation of major traffic accidents, larger vessels are obliged to install a voyage data recorder (VDR). However, not every vessel is equipped with a VDR, and the readout is often a manual process that is costly. In addition, not only ship-related information can be relevant for reconstructing traffic accidents, but also information from other entities such as meteorological services or port operators. Moreover, another major challenge is that entities tend to trust only their records, and not those of others as these could be manipulated in favor of the particular recording entity (e.g., to disguise any damage caused). This paper presents an approach to documenting arbitrary data from different entities in a trustworthy, decentralized, and tamper-proof manner to support the conflict resolution process. For this purpose, all involved entities in a traffic situation can contribute to the documentation by persisting their available data. Since maritime stakeholders are equipped with various sensors, a diverse and meaningful data foundation can be aggregated. The data is then signed by a mutually agreed upon timestamping authority (TSA). In this way, everyone can cryptographically verify whether the data has been subsequently changed. This approach was successfully applied in practice by documenting a vessel’s mooring maneuver

Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis:results from the Swiss clinical quality management cohort

Objective: To investigate the clinical phenotype and treatment response in patients with rheumatoid arthritis (RA) with and without concomitant Sjögren’s disease (SjD). Methods: In this observational cohort study, patients with RA from the Swiss Clinical Quality Management in Rheumatic Diseases registry were categorised according to the presence or absence of SjD. To assess treatment effectiveness, drug retention of tumor necrosis factor-α-inhibitors (TNFi) was compared to other mode of action (OMA) biologics and Janus kinase-inhibitors (JAKi) in RA patients with and without SjD. Adjusted hazard ratios (HR) for time to drug discontinuation were compared in crude and adjusted Cox proportional regression models for potential confounders.Results: We identified 5974 patients without and 337 patients with concomitant SjD. Patients with SjD were more likely to be female, to have a positive rheumatoid factor, higher disease activity scores, and erosive bone damage. For treatment response, a total of 6781 treatment courses were analysed. After one year, patients with concomitant SjD were less likely to reach DAS28 remission with all three treatment modalities. Patients with concomitant SjD had a higher hazard for stopping TNFi treatment (adjusted HR 1.3 [95% CI 1.07-1.6]; OMA HR 1.12 [0.91-1.37]; JAKi HR 0.97 [0.62-1.53]). When compared to TNFi, patients with concomitant SjD had a significantly lower hazard for stopping treatment with OMA (adjusted HR 0.62 [95% CI 0.46-0.84]) and JAKi (HR 0.52 [0.28-0.96]).Conclusion: RA patients with concomitant SjD reveal a severe RA phenotype, are less responsive to treatment, and more likely to fail TNFi. <br/

Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort

OBJECTIVE To compare the likelihood of achieving remission between men and women with rheumatoid arthritis (RA) after starting their first biologic or targeted synthetic disease-modifying anti-rheumatic drug (b/tsDMARD). METHODS This cohort study in the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry included RA patients starting their first b/tsDMARD (1997-31/04/2018). The odds of achieving remission at ≤12-months, defined by disease activity score 28-joints (DAS28) <2.6, were compared between men and women. Secondary analyses were adjusted for age and seropositivity, and we investigated potential mediators or factors that could explain the main findings. RESULTS The study included 2839 (76.3%) women and 883 (23.7%) men with RA. Compared to women, men were older at diagnosis and b/tsDMARD start, but had shorter time from diagnosis to b/tsDMARD (3.4 versus 5.0 years, p<0.001), and they had lower DAS28 at b/tsDMARD start. Compared to women, men had 21% increased odds of achieving DAS28-remission, with odds ratio (OR) 1.21, 95% confidence interval (CI) 1.02-1.42. Adjusting for age and seropositivity yielded similar findings (adjusted OR 1.24, 95%CI 1.05-1.46). Analyses of potential mediators suggested that the observed effect may be explained by the shorter disease duration and lower DAS28 at treatment initiation in men versus women. CONCLUSION Men started b/tsDMARD earlier than women, particularly regarding disease duration and disease activity (DAS28), and had higher odds of reaching remission. This highlights the importance of early initiation of second line treatments, and suggests to target an earlier stage of disease in women to match the benefits observed in men